Combining Executive Function Training with Cognitive Behavioral Skills Training for Schizophrenia

Optimizing Cognitive Behavioral Social Skills Training with Executive Function Training for Older Adults with Schizophrenia

Not applicable Interventional University of California, San Diego · NCT06251193

This study is testing a new program that combines brain training and social skills training to see if it can help older adults with schizophrenia improve their daily functioning.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment50 (estimated)
Ages60 Years and up
SexAll
SponsorUniversity of California, San Diego Academic / other
Locations2 sites (La Jolla, California and 1 other locations)
Trial IDNCT06251193 on ClinicalTrials.gov

What this trial studies

This research tests a blended intervention called E-CBSST, which combines Executive Function Training with Cognitive Behavioral Social Skills Training for older adults with schizophrenia or schizoaffective disorder. The study aims to determine the feasibility of E-CBSST and its effectiveness in enhancing skills learning that could lead to meaningful improvements in functioning. Participants aged 60 and older will undergo a 20-week program that includes a 2-week Executive Function Training course followed by two cycles of CBSST sessions. The intervention is designed to help prevent cognitive and functional decline in this population.

Who should consider this trial

Good fit: Ideal candidates are adults aged 60 and older with a DSM-5 diagnosis of schizophrenia or schizoaffective disorder who are clinically stable.

Not a fit: Patients with cognitive disorders, neurological conditions, or those currently experiencing major depressive episodes or substance abuse issues may not benefit from this study.

Why it matters

Potential benefit: If successful, this intervention could significantly improve the cognitive and functional abilities of older adults with schizophrenia, enhancing their quality of life.

How similar studies have performed: Previous studies have shown the efficacy of Cognitive Behavioral Social Skills Training, but the combination with Executive Function Training is a novel approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Voluntary informed consent to participate;
2. Age 60 years or older;
3. DSM-5 diagnosis of schizophrenia or schizoaffective disorder based on the SCID;
4. Be clinically stable as operationalized by (1) not having been admitted to a psychiatric hospital within the three months prior to assessment, (2) having had no change in antipsychotic medication dosage within four weeks prior to the baseline assessment, and (3) and ascertained to be clinically and medically stable by one the study investigators;
5. Be willing and able to speak English;
6. Be able to read and converse (with corrected vision or hearing if needed).

Exclusion Criteria:

1. Meets criteria for a cognitive disorder or for a neurological or other medical disorder affecting the ability to participate in Executive Function Training or CBSST;
2. Meets diagnostic criteria for bipolar disorder, current major depressive episode, or substance abuse or dependence within the six months prior to the baseline assessment except for caffeine or nicotine;
3. Received electroconvulsive therapy within six months of the baseline assessment.

Where this trial is running

La Jolla, California and 1 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions SchizophreniaSchizoaffective Disorder
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.